Physiological and pathological functions of P2X7 receptor in the spinal cord

被引:78
作者
Cotrina, Maria Luisa [1 ]
Nedergaard, Maiken [1 ]
机构
[1] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Div Glial Dis & Therapeut, Rochester, NY 14642 USA
关键词
ATP; Purinergic signaling; P2X receptors; Neuronal injury; P2X7; antagonists; TUMOR-NECROSIS-FACTOR; P2X(7) RECEPTOR; MICROGLIAL CELLS; DORSAL-HORN; RAT-BRAIN; SYNAPTIC-TRANSMISSION; EXTRACELLULAR ATP; PROTEIN-KINASE; MOLECULAR PHYSIOLOGY; ASTROCYTES INCREASES;
D O I
10.1007/s11302-009-9138-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ATP-mediated signaling has widespread actions in the nervous system from neurotransmission to regulation of proliferation. In addition, ATP is released during injury and associated to immune and inflammatory responses. Still, the potential of therapeutic intervention of purinergic signaling during pathological states is only now beginning to be explored because of the large number of purinergic receptors subtypes involved, the complex and often overlapping pharmacology and because ATP has effects on every major cell type present in the CNS. In this review, we will focus on a subclass of purinergic-ligand-gated ion channels, the P2X7 receptor, its pattern of expression and its function in the spinal cord where it is abundantly expressed. We will discuss the mechanisms for P2X7R actions and the potential that manipulating the P2X7R signaling pathway may have for therapeutic intervention in pathological events, specifically in the spinal cord.
引用
收藏
页码:223 / 232
页数:10
相关论文
共 107 条
[1]   Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development [J].
Agresti, C ;
Meomartini, ME ;
Amadio, S ;
Ambrosini, E ;
Serafini, B ;
Franchini, L ;
Volonté, C ;
Aloisi, F ;
Visentin, S .
GLIA, 2005, 50 (02) :132-144
[2]  
ANDERSON CM, 2006, TINS, V29, P258
[3]   Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis [J].
Andries, Maria ;
Van Damme, Philip ;
Robberecht, Wim ;
Van Den Bosch, Ludo .
NEUROBIOLOGY OF DISEASE, 2007, 25 (01) :8-16
[4]   Intercellular calcium signaling mediated by point-source burst release of ATP [J].
Arcuino, G ;
Lin, JHC ;
Takano, T ;
Liu, C ;
Jiang, L ;
Gao, Q ;
Kang, J ;
Nedergaard, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9840-9845
[5]  
Armstrong JN, 2002, J NEUROSCI, V22, P5938
[6]   Differential co-localisation of the P2X7 receptor subunit with vesicular glutamate transporters VGLUT1 and VGLUT2 in rat CNS [J].
Atkinson, L ;
Batten, TFC ;
Moores, TS ;
Varocqui, H ;
Erickson, JD ;
Deuchars, J .
NEUROSCIENCE, 2004, 123 (03) :761-768
[7]   P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes [J].
Ballerini, P ;
Ciccarelli, R ;
Caciagli, F ;
Rathbone, MP ;
Werstiuk, ES ;
Traversa, U ;
Buccella, S ;
Giuliani, P ;
Jiang, S ;
Nargi, E ;
Visini, D ;
Santavenere, C ;
Di Iorio, P .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2005, 18 (03) :417-430
[8]  
Bardoni R, 1997, J NEUROSCI, V17, P5297
[9]   Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms [J].
Beigi, RD ;
Kertesy, SB ;
Aquilina, G ;
Dubyak, GR .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (03) :507-519
[10]   Pharmacological characterization of recombinant human and rat P2X receptor subtypes [J].
Bianchi, BR ;
Lynch, KJ ;
Touma, E ;
Niforatos, W ;
Burgard, EC ;
Alexander, KM ;
Park, HS ;
Yu, HX ;
Metzger, R ;
Kowaluk, E ;
Jarvis, MF ;
van Biesen, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 376 (1-2) :127-138